Cancer Therapy News and Research

RSS

New findings suggest balancing Chk1 activity will produce less toxic cancer drugs

A study published by The Burnham Institute in the September edition of Molecular Cell reports that a cell-cycle checkpoint protein, known to be activated by an important class of anticancer drugs, may play crucial roles in both the hampering of therapeutic actions and aiding cancer cells to "recover" and start dividing again after treatment with these drugs.

5 Sep 2005

Recent evidence suggests caution in prescribing hormone therapy for breast cancer

One of the most effective new treatments for breast cancer is a hormone therapy. Aromatase inhibitors work by powerfully blocking the conversion of androgen precursors into estrogens, which lowers estradiol levels in the bloodstream and estrogen levels in peripheral tissues.

4 Sep 2005

Compound called GRN163L blocks lung cancer

Researchers at UT Southwestern Medical Center have found a compound that shows promise as a way to block the spread, or metastasis, of lung cancer.

1 Sep 2005

New treatment can zap cancer cells and avoid healthy tissue

Australian researchers say they have developed a cancer treatment which can identify and kill individual cancer cells.

30 Aug 2005

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Many children who undergo bone marrow transplantation (BMT) as part of cancer treatment already have dental abnormalities that leave them vulnerable to potentially life-threatening bacterial infections, according to investigators at St. Jude Children's Research Hospital. A report on this study appears in the prepublication online edition of Bone Marrow Transplantation.

29 Aug 2005

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.

29 Aug 2005

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.

26 Aug 2005

Teen cancer patients need specially designed wards

According to an National Health Advisory Body in the UK, most children and teenagers with cancer are treated on adult or paediatric wards.

25 Aug 2005

Young breast cancer sufferers need more fertility advice before treatment

According to new research led by the University of New South Wales (UNSW), Australia, 25% of young breast cancer sufferers say that there was no discussion of fertility issues at the time of diagnosis, despite the possibility of infertility after treatment.

22 Aug 2005

Discovery of signaling component that influences spread of breast cancer cells

Researchers at the Virginia Commonwealth University Massey Cancer Center have found a new signaling component that influences movement of human breast cancer cells toward epidermal growth factor.

22 Aug 2005

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

A new study finds many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals, and says investigators should be committed not just to finding novel compounds, but also to make sure final results of their studies be disseminated to the medical community.

22 Aug 2005

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.

15 Aug 2005

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

Researchers have discovered that tumors release fatty acids that interfere with the cells that are trying to kill them. Consequently, strategies that reduce the amount of fatty acids surrounding the tumors may give a boost to anti-cancer therapeutics.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Breast cancer patients could find out whether they will respond positively to chemotherapy treatment by testing for the activity of certain genes.

9 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Monash University software helps tackle cancer and aircraft design

A powerful software tool designed by academics at Monash University is being used in the UK to help develop cancer treatments and improve aircraft engine design.

2 Aug 2005

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

An analysis of more than 100 studies of cancer survivors shows that many survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis, but that those who are male, older, and less educated are less likely to adopt such changes. The term "cancer survivor" refers to a person who has been diagnosed with cancer.

25 Jul 2005

Government in Ontario will pay for three new cancer drugs

Canadian Health Minister George Smitherman has announced that the government will add three new and expensive cancer-fighting drugs to the list of medications it funds.

25 Jul 2005

Cancer Therapy News and Research

New findings suggest balancing Chk1 activity will produce less toxic cancer drugs

Recent evidence suggests caution in prescribing hormone therapy for breast cancer

Compound called GRN163L blocks lung cancer

New treatment can zap cancer cells and avoid healthy tissue

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

Teen cancer patients need specially designed wards

Young breast cancer sufferers need more fertility advice before treatment

Discovery of signaling component that influences spread of breast cancer cells

A cell's energy level is critical to its survival

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

FDA approval sought for Pfizer's new cancer drug

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Monash University software helps tackle cancer and aircraft design

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

Government in Ontario will pay for three new cancer drugs

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News